| Identification | |
| Name: | Imatinib (Piperidine)-N-oxide |
| Synonyms: | 4-[(4-Methyl-4-oxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide;CGP 71422;Imatinib (Piperidine)-N-oxide |
| CAS: | 571186-91-9 |
| Molecular Formula: | C29H31N7O2 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C29H31N7O2/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-35-14-16-36(2,38)17-15-35/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) |
| Molecular Structure: | ![(C29H31N7O2) 4-[(4-Methyl-4-oxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]pheny...](https://img.guidechem.com/structure/571186-91-9.gif) |
| Properties | |
| Specification: | Pale Yellow Solid usageEng:Imatinib (Piperidine)-4-oxide is an impurity of Imatinib (Gleevec) (G407000). Imatinib impurity D. |
| Usage: | A metabolite of Imatinib |
| Safety Data | |
 |
|
